Hot Features
Premium
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Zeitraum:
Zeichenmodus:
| Volumen | 0 |
|
|||||
| News | - | ||||||
| Tageshoch | Niedrig Hoch |
||||||
| Tagestief | |||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Cyteir Therapeutics Inc | CYT | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,00 | 0,00% | 3,02 | 02:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 3,02 |
| Trades | Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 1,67 - 3,19 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| - | 0 | US$ 3,02 | USD |
Finanzwerte CYT
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| US$ 108,71M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Cyteir Therapeutics
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 07.3.2024 | 22:31 | Edgar (US Regulatory) | Form 8-K - Current report |
| 07.3.2024 | 22:30 | Business Wire | Cyteir Announces Timeline for Voluntarily Delisting from.. |
| 06.3.2024 | 00:11 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 15.2.2024 | 01:36 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 14.2.2024 | 01:14 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 27.12.2023 | 22:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 14.12.2023 | 22:00 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 07.12.2023 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 05.12.2023 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 22.11.2023 | 19:47 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 17.11.2023 | 22:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 06.11.2023 | 22:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
Forum Cyteir Therapeutics
Keine Diskussionen Gefunden.Neuen Thread Erstellen
CYT Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Monat | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 3 Monate | 3,16 | 3,19 | 2,99 | 3,06 | 304.695 | -0,14 | -4,43% |
| 6 Monate | 3,03 | 3,19 | 2,97 | 3,06 | 134.689 | -0,01 | -0,33% |
| 1 Jahr | 2,14 | 3,19 | 1,67 | 2,80 | 180.093 | 0,88 | 41,12% |
| 3 Jahre | 16,50 | 23,10 | 1,13 | 5,54 | 135.425 | -13,48 | -81,70% |
| 5 Jahre | 16,50 | 23,10 | 1,13 | 5,54 | 135.425 | -13,48 | -81,70% |
